Literature DB >> 10503971

Complexation graft copolymer networks: swelling properties, calcium binding and proteolytic enzyme inhibition.

F Madsen1, N A Peppas.   

Abstract

Graft copolymer networks of poly(methacrylic acid-g-ethylene glycol) were prepared by free radical solution UV-polymerization of methacrylic acid (MAA) and poly(ethylene glycol) monomethacrylate. Dynamic swelling studies indicated that complexation/decomplexation processes occurred due to hydrogen bonding between the carboxylic groups of the poly(methacrylic acid) (PMAA) and the ether groups of poly(ethylene glycol) (PEG). The effects of copolymer composition, graft chain molecular weight, environmental pH and ion content on network structure and gel behavior were studied. The largest change in swelling ratio and mesh size of the gel structure was observed in gels containing the highest content of PEG and the longest molecular weight PEG grafts. Complexation was greatest in hydrogels containing the longest PEG grafts and equimolar amounts of MAA and PEG. The swelling was much less pronounced in the presence of calcium chloride compared to sodium chloride which could be attributed to the complexation of calcium of the carboxylic groups in the polymer. The copolymers showed significant but less binding of calcium compared to poly(acrylates) like Carbopol 934P and polycarbophil. The P(MAA-g-EG) copolymers inhibited trypsin but to a lesser extent than the known protease inhibitors Carbopol 934P and polycarbophil. Results suggest that P(MAA-g-EG) copolymers are good drug delivery carrier candidates due to their pH-sensitive and controllable swelling behavior. Additionally, they possess some protease inhibition effect along with their bioadhesive properties which make them promising carriers for peptides or proteins.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10503971     DOI: 10.1016/s0142-9612(99)00071-x

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  27 in total

Review 1.  Application of in situ polymerization for design and development of oral drug delivery systems.

Authors:  Ndidi Ngwuluka
Journal:  AAPS PharmSciTech       Date:  2010-11-11       Impact factor: 3.246

2.  Novel oral insulin delivery systems based on complexation polymer hydrogels: single and multiple administration studies in type 1 and 2 diabetic rats.

Authors:  Mariko Morishita; Takahiro Goto; Koji Nakamura; Anthony M Lowman; Kozo Takayama; Nicholas A Peppas
Journal:  J Control Release       Date:  2005-12-02       Impact factor: 9.776

Review 3.  Past, present, and future technologies for oral delivery of therapeutic proteins.

Authors:  Rajesh Singh; Shailesh Singh; James W Lillard
Journal:  J Pharm Sci       Date:  2008-07       Impact factor: 3.534

4.  Assessment of poly(methacrylic acid-co-N-vinyl pyrrolidone) as a carrier for the oral delivery of therapeutic proteins using Caco-2 and HT29-MTX cell lines.

Authors:  Daniel A Carr; Nicholas A Peppas
Journal:  J Biomed Mater Res A       Date:  2010-02       Impact factor: 4.396

5.  pH-Responsive poly(itaconic acid-co-N-vinylpyrrolidone) hydrogels with reduced ionic strength loading solutions offer improved oral delivery potential for high isoelectric point-exhibiting therapeutic proteins.

Authors:  Michael C Koetting; Nicholas A Peppas
Journal:  Int J Pharm       Date:  2014-05-20       Impact factor: 5.875

6.  Quantifying Tight Junction Disruption Caused by Biomimetic pH-Sensitive Hydrogel Drug Carriers.

Authors:  Omar Z Fisher; Nicholas A Peppas
Journal:  J Drug Deliv Sci Technol       Date:  2008-01       Impact factor: 3.981

7.  In vitro evaluation of polyethylene glycol based microparticles containing azithromycin.

Authors:  Shunmugaperumal Tamilvanan; Vinay Kumar; Deepak Sharma; Ashutosh Thakur
Journal:  Drug Deliv Transl Res       Date:  2014-04       Impact factor: 4.617

8.  Synthesis, characterization and in vivo efficacy of PEGylated insulin for oral delivery with complexation hydrogels.

Authors:  Anthony D Tuesca; Collin Reiff; Jeffrey I Joseph; Anthony M Lowman
Journal:  Pharm Res       Date:  2009-01-15       Impact factor: 4.200

9.  pH-responsive and enzymatically-responsive hydrogel microparticles for the oral delivery of therapeutic proteins: Effects of protein size, crosslinking density, and hydrogel degradation on protein delivery.

Authors:  Michael Clinton Koetting; Joseph Frank Guido; Malvika Gupta; Annie Zhang; Nicholas A Peppas
Journal:  J Control Release       Date:  2015-12-02       Impact factor: 9.776

10.  Novel complexation hydrogels for oral peptide delivery: in vitro evaluation of their cytocompatibility and insulin-transport enhancing effects using Caco-2 cell monolayers.

Authors:  Hideki Ichikawa; Nicholas A Peppas
Journal:  J Biomed Mater Res A       Date:  2003-11-01       Impact factor: 4.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.